The largest database of trusted experimental protocols

3 protocols using pe cy7 anti human ifn γ

1

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After treated with surface antibodies at 4°C for 30 minutes, cells were prepared with Transcription Factor Buffer Set (BD Biosciences) according to the manufacturer’s instructions for intracellular staining, and then incubated with intra-nuclear antibodies for 45 min. Cells were collected with a Cytek Athena (Cytek Biosciences). FlowJo software (Tree Star) were used to analyze the flow cytometry results. The blank control (cells unstained), single-stained control (PC5.5, APC-CY7, PE-cy7-A, APC-A, PE and FITC), and Fluorescence-Minus-One (FMO) control were set. The panel was designed as PC5.5 (CD8), APC-CY7 (CD4), APC-A (LEPR second antibody), PE (perforin), FITC (Granzyme B), and PE-cy7 (IFN-γ). The following antibodies were used: Alexa Flour 647 Donkey anti-rabbit IgG (BioLegend), Rabbit Anti-Leptin receptor antibody (bs-0410R, Bioss), APC-Cy7 anti-human CD4 (BD Biosciences), Percp-Cy5.5 anti-human CD8 (BD Biosciences), PE anti-human Perforin (BD Biosciences), FITC anti-human/mouse Granzyme B (Granzyme B, BioLegend), PE-Cy7 anti-human IFN-γ (BioLegend), Zombie Aqua Fixable Viability Kit (BioLegend), APC-Cy7 anti-mouse CD4 (Abcam), Percp-Cy5.5 anti-mouse CD8 (Abcam), PE anti-mouse Perforin (Abcam), FITC anti-mouse/human granzyme B (BioLegend), PE-Cy7 anti-mouse IFN-γ (Abcam).
+ Open protocol
+ Expand
2

Activation and Cytokine Profiling of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from fresh blood of healthy donors by Ficoll–Hypaque centrifugation. Then, PBMCs were resuspended with RCA reaction buffer for indicated time points (0.5, 1 or 2 h), while control group were treated with RCA buffer without phi29 DNA Polymerase for 2 h. After RCA reaction, PBMCs were washed with PBS twice and then collected immediately as inactivated PBMCs. For activation group, PBMCs were pretreated with agonistic anti-CD3/CD28 Abs (1 μg/mL) for 24 h before collection. Then inactivated or activated PBMCs were stained in PBS with the following Abs, including Zombie NIR™ Fixable Viability Kit (Biolegend #423105), PerCP/Cyanine5.5 anti-human CD3 (Biolegend #317336), PE anti-human CD69 (Biolegend #310906), APC anti-human IL-2 (Biolegend #500310), PE/Cy7 anti-human IFN-γ (Biolegend #502528), and then detected on a flow cytometer (BD Biosciences, BD FACSVerse, San Jose, CA, USA) and analysed with FlowJo software (Becton, Dickinson and Company, Ashland, OR, USA).
+ Open protocol
+ Expand
3

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were first stained with LIVE/DEAD™ Fixable Aqua (Thermo Fisher, cat. L34957), followed by staining with antibodies against various surface markers. Samples were then acquired by a FACS instrument (CytoFLEX LX, Beckman Coulter). For intracellular staining, GolgiPlug (BD) was added upon at the beginning of T cell and target cell co-culture and cells were cultured for 6 h. Samples were then processed with the Cytofix/cytoperm kit (BD, cat. 555028) following the manufacture's protocol. The following antibodies were used: APC-eFluor 780 anti-human CD3 (Thermo Fisher, cat. 47003642), FITC anti-human CD8a (Biolegend, cat. 301006), BV605 anti-mouse TCRβ (Biolegend, cat. 109241), APC anti-human CD137 (Biolegend, cat. 309810), PECy7 anti-human IFN-γ (Biolegend, cat. 502528), Alx700 anti-human TNF-α (Biolegend, cat. 502928), PE anti-human IL2 (Biolegend, cat. 500307), PerCPCy5.5 anti-human CD107a (Biolegend, cat. 328616). HLA-A2/AFP158 tetramer was kindly provided by NIH Tetramer core facility at Emory University. All data were analyzed with FlowJo V10 software (FlowJo).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!